129
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The efficacy and safety of S-flurbiprofen plaster in the treatment of knee osteoarthritis: a phase II, randomized, double-blind, placebo-controlled, dose-finding study

, , , &
Pages 867-880 | Published online: 11 Apr 2017

References

  • MurakiSAkuneTOkaHAssociation of radiographic and symptomatic knee osteoarthritis with health-related quality of life in a population-based cohort study in Japan: the ROAD studyOsteoarthritis Cartilage2010181227123420633679
  • PeatGMcCarneyRCroftPKnee pain and osteoarthritis in older adults: a review of community burden and current use of primary health careAnn Rheum Dis200160919711156538
  • FransenMBridgettLMarchLHoyDPensergaEBrooksPThe epidemiology of osteoarthritis in AsiaInt J Rheum Dis20111411312121518309
  • WittenauerRSmithLAdenKPriority medicines for Europe and the world update report, 2013Priority medicines for Europe and the world “A public health approach to innovation. Background paper 6.12 osteoarthritisWorld Health Organization Available from: http://www.who.int/medicines/areas/priority_medicines/BP6_12Osteo.pdfAccessed March 23, 2017
  • American Academy of Orthopaedic SurgeonsTreatment of Osteoarthritis of the Knee, Evidence-Based Guideline2nd edn2013 Available from: http://www.aaos.org/cc_files/aaosorg/research/guidelines/treatmentofosteoarthritisofthekneeguideline.pdfAccessed March 23, 2017
  • McAlindonTEBannuruRRSullivanMCOARSI guidelines for the non-surgical management of knee osteoarthritisOsteoarthritis Cartilage20142236338824462672
  • National Clinical Guideline CentreOsteoarthritis: Care and Management in Adults2014 Available from: https://www.nice.org.uk/guidance/cg177/evidence/full-guideline-191761309Accessed March 23, 2017
  • HuangJQSridharSHuntRHRole of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysisLancet2002359142211809181
  • SakamotoCSuganoKOtaSCase-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in JapanEur J Clin Pharmacol20066276577216821007
  • WolfeMMLichtensteinDRSinghGGastrointestinal toxicity of non-steroidal antiinflammatory drugsN Engl J Med19993401888189910369853
  • SinhaMGautamLShuklaPKKaurPSharmaSSinghTPCurrent perspectives in NSAID-induced gastropathyMediators Inflamm2013201325820923576851
  • CarabazaACabréFRotllanEStereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugsJ Clin Pharmacol1996365055128809635
  • PeskarBMKlugeSPeskarBASoglowekSMBruneKEffects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivoProstaglandins1991425155311801061
  • Froben 100mg Tablets (flurbiprofen) [package insert]Maidenhead, Berkshire, UKBGP Products, Ltd.2015
  • MemeoAGarofoliFPerettiGEvaluation of the efficacy and tolerability of a new topical formulation of flurbiprofen in acute soft tissue injuriesDrug Invest19924441449
  • TanakaSSonodaHNakabayashiKNamikiAPreoperative flurbiprofen provides pain relief after laparopscopic cholecystectomyMasui199746679683 Japanese9185468
  • SugimotoMTodaYHoriMAnalgesic effect of the newly developed S(+)-flurbiprofen plaster (SFPP) on inflammatory pain in a rat adjuvant-induced arthritis modelDrug Dev Res201677202826763139
  • SugimotoMTodaYHoriMTopical anti-inflammatory and analgesic effects of multiple applications of S(+)-flurbiprofen plaster (SFPP) in a rat adjuvant-induced arthritis modelDrug Dev Res20167720621127241582
  • YatabaIOtsukaNMatsushitaIPlasma pharmacokinetics and synovial concentrations of S-flurbiprofen plaster in humansEur J Clin Pharmacol201672535926438533
  • European Medicines AgencyCommittee for medicinal products for human use, guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis, Draft2009 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003443.pdfAccessed March 23, 2017
  • U.S. Department of Health and Human Services, Food and Drug AdministrationGuidance for industry: clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA), draft guidance1999 Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071577.pdfAccessed March 23, 2017
  • KellgrenJHLawrenceJSRadiological assessment of osteoarthrosisAnn Rheum Dis19571649450213498604
  • DayRMorrisonBLuzaAA randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/ibuprofen comparator study groupArch Intern Med20001601781178710871971
  • GebaGPWeaverALPolisABDixonMESchnitzerTJVioxx, Acetaminophen, Celecoxib Trial (VACT) GroupEfficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trialJAMA2002287647111754710
  • HiragaKOhashiYEfficacy evaluation of analgesic agents used for cancer pain management by visual analogue scalePain Res199914919 Japanese (English abstract)
  • DireiserRLTisne-CamusMDHEP plasters as a topical treatment of knee osteoarthritis – a double-blind placebo-controlled studyDrugs Exp Clin Res1993191171238112200
  • SugawaraSKurokiYTateishiAThe effects of LOXONIN PAP 100mg (hydrogel patch containing loxoprofen sodium) for the treatment of patients with osteoarthritis of the knee – randomized, double-blind clinical study with loxoprofen sodium tabletsJ Clin Ther Med200622393409 Japanese (English abstract)
  • NagayaINiwaSMatsuiNStudy for defining the adequate concentration of the active ingredient of KPT-220 – double-blind study in gonarthrosis deformansClin Rep199327245269 Japanese (English abstract)
  • BusseJWBartlettSJDougadosMOptimal strategies for reporting pain in clinical trials and systematic reviews: recommendations from an OMERACT 12 workshopJ Rheumatol2015421962197525979719
  • TubachFRavaudPBaronGEvaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvementAnn Rheum Dis200564293315208174
  • TubachFRavaudPBaronGEvaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom stateAnn Rheum Dis200564343715130902
  • BrühlmannPMichelBATopical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trialClin Exp Rheumatol20032119319812747273
  • EcclesRMenthol and related cooling compoundsJ Pharm Pharmacol1994466186307529306
  • JoharPGroverVToppRBehmDGA comparison of topical menthol to ice on pain, evoked tetanic and voluntary force during delayed onset muscle sorenessInt J Sports Phys Ther2012731432222666646
  • BannuruRRMcAlindonTESullivanMCWongJBKentDMSchmidCHEffectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trialsAnn Intern Med201516336537226215539
  • ZhangWRobertsonJJonesACDieppePADohertyMThe placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trialsAnn Rheum Dis2008671716172318541604
  • KawamuraNShinkaiNYamauchiHTakayamaSComparison of poultice-type and tape-type patches containing ketoprofen on human skin irritationJ Toxicol Sci20032841542514746345
  • European Medicines AgencyAssessment report for ketoprofen containing medicinal products (topical formulations)2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Ketaprofen_107/WC500117251.pdfAccessed March 23, 2017
  • GuyRHKumaHNakanishiMSerious photocontact dermatitis induced by topical ketoprofen depends on the formulationEur J Dermatol20142436537124721981